BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

648 related articles for article (PubMed ID: 33526393)

  • 1. Initial Single-Center ST-Segment Elevation Myocardial Infarction Experience in New York Before and During the COVID-19 Pandemic.
    Medranda GA; Brahmbhatt K; Alawneh B; Marzo KP; Schwartz RK; Green SJ
    Cardiovasc Revasc Med; 2022 Jan; 34():80-85. PubMed ID: 33526393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction Before and During COVID in New York.
    Hannan EL; Wu Y; Cozzens K; Friedrich M; Tamis-Holland J; Jacobs AK; Ling FSK; King SB; Venditti FJ; Walford G; Berger PB; Kirtane AJ; Kamran M
    Am J Cardiol; 2021 Mar; 142():25-34. PubMed ID: 33301770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the COVID-19 Pandemic on ST-elevation Myocardial Infarction from a Single-center Experience in Tokyo.
    Watanabe Y; Miyachi H; Mozawa K; Yamada K; Oka E; Shiomura R; Sugizaki Y; Matsuda J; Nakata J; Tara S; Tokita Y; Iwasaki YK; Yamamoto T; Takano H; Shimizu W
    Intern Med; 2021 Dec; 60(23):3693-3700. PubMed ID: 34565777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of COVID-19 on short-term prognosis of ST-segment elevation myocardial infarction patients receiving primary percutaneous coronary intervention in Wuhan China.
    Lu Q; Wang JL; Chen ZN; Fu WB; Liu HJ; Ding SF
    Rev Cardiovasc Med; 2021 Mar; 22(1):247-256. PubMed ID: 33792269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the COVID-19 Pandemic on Treatment Times for ST-Elevation Myocardial Infarction: Observations from the Los Angeles County Regional System.
    Shavelle DM; Bosson N; French WJ; Thomas JL; Niemann JT; Gausche-Hill M; Rollman JE; Rafique AM; Klomhaus AM; Kloner RA
    Am J Cardiol; 2024 Feb; 213():93-98. PubMed ID: 38016494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Clinical Outcomes in Patients with ST Elevation Myocardial Infarction with Percutaneous Coronary Intervention and the Use of a Telemedicine App Before and After the COVID-19 Pandemic at a Center in Beijing, China, from August 2019 to March 2020.
    Nan J; Meng S; Hu H; Jia R; Chen W; Li Q; Zhang T; Song K; Wang Y; Jin Z
    Med Sci Monit; 2020 Sep; 26():e927061. PubMed ID: 32938901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase of Myocardial Ischemia Time and Short-Term Prognosis of Patients with Acute Myocardial Infarction during the First COVID-19 Pandemic Wave.
    Budrys P; Lizaitis M; Cerlinskaite-Bajore K; Bajoras V; Rodevic G; Martinonyte A; Dieckus L; Badaras I; Serpytis P; Gurevicius R; Visinskiene R; Buivydas R; Volodko A; Urbonaite E; Celutkiene J; Davidavicius G
    Medicina (Kaunas); 2021 Nov; 57(12):. PubMed ID: 34946241
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of SARS-CoV-2 pandemic on ST-elevation myocardial infarction admissions and outcomes in a Portuguese primary percutaneous coronary intervention center: Preliminary Data.
    Azul Freitas A; Baptista R; Gonçalves V; Ferreira C; Milner J; Lourenço C; Costa S; Franco F; Monteiro S; Gonçalves F; Gonçalves L
    Rev Port Cardiol (Engl Ed); 2021 Jul; 40(7):465-471. PubMed ID: 34274091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the COVID-19 Pandemic on Patient Delay and Clinical Outcomes for Patients With Acute Myocardial Infarction.
    Choi H; Lee JH; Park HK; Lee E; Kim MS; Kim HJ; Park BE; Kim HN; Kim N; Jang SY; Bae MH; Yang DH; Park HS; Cho Y
    J Korean Med Sci; 2022 May; 37(21):e167. PubMed ID: 35638194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of COVID-19 pandemic on STEMI care: An expanded analysis from the United States.
    Garcia S; Stanberry L; Schmidt C; Sharkey S; Megaly M; Albaghdadi MS; Meraj PM; Garberich R; Jaffer FA; Stefanescu Schmidt AC; Dixon SR; Rade JJ; Smith T; Tannenbaum M; Chambers J; Aguirre F; Huang PP; Kumbhani DJ; Koshy T; Feldman DN; Giri J; Kaul P; Thompson C; Khalili H; Maini B; Nayak KR; Cohen MG; Bangalore S; Shah B; Henry TD
    Catheter Cardiovasc Interv; 2021 Aug; 98(2):217-222. PubMed ID: 32767652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of patients with ST-segment myocardial infarction admitted during the COVID-19 pandemic : A prospective, observational study from a tertiary care center in Germany.
    Rattka M; Winsauer C; Stuhler L; Thiessen K; Baumhardt M; Stephan T; Rottbauer W; Imhof A
    Herz; 2022 Jun; 47(3):258-264. PubMed ID: 34402922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ST-Segment-Elevation Myocardial Infarction During COVID-19 Pandemic: Insights From a Regional Public Service Healthcare Hub.
    Gramegna M; Baldetti L; Beneduce A; Pannone L; Falasconi G; Calvo F; Pazzanese V; Sacchi S; Pagnesi M; Moroni F; Ajello S; Melisurgo G; Agricola E; Camici PG; Scandroglio AM; Landoni G; Ciceri F; Zangrillo A; Cappelletti AM
    Circ Cardiovasc Interv; 2020 Aug; 13(8):e009413. PubMed ID: 32791953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive Management of Acute Myocardial Infarctions During the Initial Wave of the COVID-19 Pandemic.
    Talmor N; Ramachandran A; Brosnahan SB; Shah B; Bangalore S; Razzouk L; Attubato M; Feit F; Thompson C; Smilowitz NR
    J Invasive Cardiol; 2022 Jan; 34(1):E32-E38. PubMed ID: 34866048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case Rates, Treatment Approaches, and Outcomes in Acute Myocardial Infarction During the Coronavirus Disease 2019 Pandemic.
    Gluckman TJ; Wilson MA; Chiu ST; Penny BW; Chepuri VB; Waggoner JW; Spinelli KJ
    JAMA Cardiol; 2020 Dec; 5(12):1419-1424. PubMed ID: 32766756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the SARS-CoV-2 Pandemic on Primary Percutaneous Coronary Intervention for Patients with ST-Elevation Myocardial Infarction.
    Matsubara Y; Izumikawa T; Washimi S; Yamada T; Hashimoto S; Taniguchi N; Nakajima S; Hata T; Takahashi A
    Int Heart J; 2021; 62(6):1230-1234. PubMed ID: 34853218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience of ST Segment Elevation Myocardial Infarction Management During COVID-19 Pandemic From the Mainland of China.
    Zhang F; Song X; Dang Y
    Cardiovasc Revasc Med; 2021 Jul; 28():92-94. PubMed ID: 32855085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased door-to-balloon time in patients with ST-segment elevation myocardial infarction during the early COVID-19 pandemic in South Korea: An observational study.
    Ryu S; Kim D; Jung LY; Kim B; Lee CS
    Medicine (Baltimore); 2022 Jul; 101(30):e29596. PubMed ID: 35905280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment delays and in-hospital outcomes in acute myocardial infarction during the COVID-19 pandemic: A nationwide study.
    Erol MK; Kayıkçıoğlu M; Kılıçkap M; Güler A; Yıldırım A; Kahraman F; Can V; Inci S; Baysal SS; Er O; Zeybey U; Kafkas Ç; Yayla Ç; Arin CB; Aktaş I; Yalçın AA; Genç Ö
    Anatol J Cardiol; 2020 Nov; 24(5):334-342. PubMed ID: 33122486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of COVID-19 on percutaneous coronary intervention for ST-elevation myocardial infarction.
    Kwok CS; Gale CP; Kinnaird T; Curzen N; Ludman P; Kontopantelis E; Wu J; Denwood T; Fazal N; Deanfield J; de Belder MA; Mamas M
    Heart; 2020 Dec; 106(23):1805-1811. PubMed ID: 32868280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the COVID-19 pandemic on access to primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Çinier G; Hayıroğlu M; Pay L; Yumurtaş A; Tezen O; Parsova KE; Tekkesin I
    Turk Kardiyol Dern Ars; 2020 Oct; 48(7):640-645. PubMed ID: 33034585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.